Ayuda
Ir al contenido

Dialnet


Resumen de Inhaled corticosteroids may have a protective effect against coronavirus infection

Alicia Armentia Medina, Sara Fernández Cortés, Angela Moro Simón, Blanca Martín Armentia, Sara Martín Armentia, Daniel Ramos Pollo, Claudio Navarro Cañadas, Javier Visa Caño, Álvaro Sanz Rubiales, Joaquín Rodriguez Fra, Sara García Vaquero, Marta Cano Pazos, Jesús Galán de la Calle, Edgardo Raul Lowell, Cristina Crespo Soto, Carmen Sánchez Toledano, Aurora Sacristán Salgado

  • Background: Spain has been severely affected by the COVID-19 epidemic, with 195,944 persons infected and 20,453 deaths at the time of writing. Older people with respiratory or cardiac conditions are most at risk.

    Objective: The aim was to compare respiratory symptoms in nursing home residents and patients with uncontrolled asthma, who are considered vulnerable to COVID-19.

    Methods: We studied 134 nursing home residents and 139 patients with uncontrolled asthma, groups vulnerable to COVID-19. Demographic characteristics, clinical manifestations, outcomes, key laboratory results, and radiological images were collected from medical records. COVID-19 infection was detected by polymerase chain reaction (PCR).

    Results: Thirteen (9.3%) patients with uncontrolled asthma, all receiving inhaled corticosteroids were infected by COVID-19. Eighty (60%) nursing home residents were infected; only 28, all of whom had received inhaled corticosteroids, had a good prognosis.

    Conclusions: Early treatment with inhaled corticosteroids may be helpful in COVID-19 infection. Persons with an allergy might have some protective mechanisms against coronavirus.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus